All posts tagged "COVID-19"
-
2151BiotechTodos Medical (TOMDF) COVID-19 Oral Antiviral Takes Death off Table
Todos Medical (OTCMKTS: TOMDF) today announced excellent Phase 1/2 results that appear to take dying from COVID-19 off the table. In a...
-
156BiotechStemcell Nutraceutical Leader ‘Stemtech’ Going Public via Merger with (OTCMKTS: GNTW) Globe Net Wireless Corp.
Glory Days Awaken the Sleeping Giant Globe Net Wireless Corp. (OTCMKTS: GNTW) isn’t your typical reverse merger deal because the acquiring asset...
-
241BiotechCytoDyn (CYDY) Shorts Throttle Up Bashing Ahead of August Super News Cycle
Short attack timed to capitalize on consolidation and thin trading The Oregonian misquotes and twists statements taken out of context SEC case...
-
2541BiotechCytoDyn (CYDY) at Crossroads: Past and Current Leadership Collide in Epic Grudgematch
Latest 8-K filing settles dispute for $7.6 million but paves way for Pestell share repurchase at par 13-D Group is outspoken but...
-
2391BiotechCytoDyn’s Smoking Gun For an Immediate EUA
The controversy surrounding CytoDyn Inc. (OTCMKTS: CYDY) stock is startling. An aggressive pack of short sellers claim its leronlimab Covid trial...
-
140Momentum & GrowthLow Floater Boon Industries (OTCMKTS: BNOW) Breaks Silence with Mega Projections and COVID-19 Product Launch
Boon Industries (OTCMKTS: BNOW) has been quiet for the past year and finally broke its silence with an update letter from its...
-
324BiotechRISE of the COVID-19 Therapeutics CytoDyn (OTCMKTS: CYDY) & Humanigen (NASDAQ:HGEN)
Enrollment Key Metric in Therapeutic Race Philippines EUA Relevant to CytoDyn, not Humanigen Highly Credentialed Humanigen Team Possibility of NAS...
-
34.8KBiotechWhy RLFTF Stock Is The Best COVID-19 Bet
Right now a lot of traders and investors are asking what the next move to make in regards to COVID-19 plays. Many...
-
15.0KBiotechTonix Pharmaceuticals: A Bull Run Is Coming
Tonix Pharmaceuticals is a name that we covered last month before its run to $2.50, which you can read here. What attracted...
-
11.2KBiotechVBI Vaccines Stock Destined For New Highs
VBI Vaccines stock has dropped along with the other COVID-19 vaccine players after Russia announced it developed a coronavirus vaccine. Like many...